{"id":15630,"date":"2023-07-20T00:00:00","date_gmt":"2023-07-20T00:00:00","guid":{"rendered":"https:\/\/makingpharmaindustry.it\/non-categorizzato\/healthbiotech-accelerator-deloitte-officine-innovazione\/"},"modified":"2023-08-28T08:47:26","modified_gmt":"2023-08-28T08:47:26","slug":"healthbiotech-accelerator-deloitte-officine-innovazione","status":"publish","type":"post","link":"https:\/\/makingpharmaindustry.it\/en\/business-en-2\/startup-en\/healthbiotech-accelerator-deloitte-officine-innovazione\/","title":{"rendered":"Health&Biotech Accelerator | Deloitte Officine Innovazione"},"content":{"rendered":"\r\n

The second Partners Board meeting was held on Friday, July 7, 2023, to select the finalist startups that will follow the path of the Health&BioTech Accelerator<\/a>, a project of Deloitte Officine Innovazione. Partners of excellence for this third edition of the event, the corporate and clinical partners are:\u00a0Intesa San Paolo RBM salute<\/a>,\u00a0MSD Italia<\/a>,\u00a0Gruppo San Donato<\/a>\u00a0,Humanitas<\/a>,\u00a0Istituto Italiano di Tecnologia<\/a>,\u00a0Universit\u00e0 di Milano<\/a>,\u00a0teleserenit\u00e0<\/a>,\u00a0istituto romagnolo per lo studio dei tumori Dino Amadori e Servizio Sanitario ragionale Emilia Romagna<\/a>;technological partner is\u00a0aws<\/a>\u00a0( amazon web service). The investing partners are:\u00a0Kairos<\/a>,\u00a0Digital Magics<\/a>,\u00a0Italian Angels<\/a>,\u00a0Panak\u00e8s<\/a>,\u00a0Claris ventures<\/a>. finally the media partners are: InnovUp<\/a>,\u00a0Notizie.it<\/a>\u00a0e\u00a0MakingLife<\/a>.<\/p>\r\n\r\n\r\n\r\n

The selection and objectives<\/h3>\r\n\r\n\r\n\r\n

As many as 288 startups from 40 countries applied to the initiative, selected according to criteria of innovation, advanced diagnostics and digital health; prevention, telehealth and assisted living are other criteria taken into consideration during the participant selection phase.<\/p>\r\n\r\n\r\n\r\n

\"HEALTH&BIOTECH<\/figure>\r\n\r\n\r\n\r\n

During these months, the \u00a0Deloitte Officine Innovazione<\/a>\u00a0 Team held more than 50 meetings with the selected startups in order to deepen their solutions and best present them to the partners they would meet at the second selection.<\/p>\r\n\r\n\r\n\r\n

The ultimate goal of the Health&BioTech Accelerator, which through its first two editions has established itself as the largest Open Innovation program in Italy in the life sciences and healthcare sector, is to identify the most innovative companies globally that meet the innovation goals that the life sciences field is heading for. The idea of “accelerating” the activity of startups that can develop and launch new products on the market has proven successful, enhancing Italian excellence by capitalizing on the global innovation presented at this event.<\/p>\r\n\r\n\r\n\r\n

Deloitte Officine Innovazione team, together with its many prestigious partners, identified last week the 19 startups that most represent the innovation trends in demand. Geographically, 10 countries are involved, among which Italy is a prominent element with 8 startups out of 19, a truly remarkable number and a source of great admiration. In second place are Switzerland and Austria, but there is no shortage of the United Kingdom, Portugal, Finland, Switzerland and Denmark, while Israel and Turkey represent the international scene.<\/p>\r\n\r\n\r\n\r\n

\"HEALTH&BIOTECH<\/figure>\r\n\r\n\r\n\r\n

The startups<\/h2>\r\n\r\n\r\n\r\n

Among the 19 selected stratups, the majority pate work in advanced diagnostics and digital therapies and preventions, but we also see companies in assisted living, robotics, and tele-medicine represented.<\/p>\r\n\r\n\r\n\r\n

We are now in the central phase of the acceleration: after the selection and the day on Friday, July 7, when the finalist candidates were chosen, in the coming days the startups will have to work on the presentation of their projects, which will be evaluated on the final day of presentation to the public, institutions and the business innovation community, which will be held on July 18 in an in-person event that will decide the winner.<\/p>\r\n\r\n\r\n\r\n

Below are the startups selected as finalists:<\/p>\r\n\r\n\r\n\r\n